当前位置: X-MOL 学术Clin. Cardiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Differences in activated clotting time and total unfractionated heparin dose during pulmonary vein isolation in patients on different anticoagulation therapy
Clinical Cardiology ( IF 2.7 ) Pub Date : 2021-07-01 , DOI: 10.1002/clc.23681
Ivan Zeljkovic 1 , Sandro Brusich 2 , Daniel Scherr 3 , Vedran Velagic 4 , Vassil Traykov 5 , Andrej Pernat 6 , Ante Anic 7 , Janko Szavits Nossan 8 , Matevz Jan 9 , Zoran Bakotic 10 , Borka Pezo Nikolic 4 , Vjekoslav Radeljic 1 , Ana Bojko 1 , Ivica Benko 1, 11 , Sime Manola 1, 11 , Nikola Pavlovic 1, 11
Affiliation  

Periprocedural pulmonary vein isolation (PVI) anticoagulation requires balancing between bleeding and thromboembolic risk. Intraprocedural anticoagulation is monitored by activated clotting time (ACT) with target value >300 s, and there are no guidelines specifying an initial unfractionated heparin (UFH) dose.

中文翻译:

不同抗凝治疗患者肺静脉隔离期间活化凝血时间和普通肝素总剂量的差异

围手术期肺静脉隔离 (PVI) 抗凝需要在出血和血栓栓塞风险之间取得平衡。术中抗凝通过活化凝血时间 (ACT) 监测,目标值 >300 秒,并且没有指定初始普通肝素 (UFH) 剂量的指南。
更新日期:2021-08-16
down
wechat
bug